These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7181051)
1. Side effects during immunotherapy with purified grass pollen extracts. Osterballe O Allergy; 1982 Nov; 37(8):553-62. PubMed ID: 7181051 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with grass pollen major allergens. Osterballe O Allergy; 1982 Aug; 37(6):379-88. PubMed ID: 7137533 [TBL] [Abstract][Full Text] [Related]
3. Nasal and skin sensitivity during immunotherapy with two major allergens 19, 25 and partially purified extract of timothy grass pollen. Osterballe O Allergy; 1982 Apr; 37(3):169-77. PubMed ID: 6814282 [TBL] [Abstract][Full Text] [Related]
4. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Klimek L; Schendzielorz P; Pinol R; Pfaar O Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165 [TBL] [Abstract][Full Text] [Related]
5. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783 [TBL] [Abstract][Full Text] [Related]
6. Safety of inhalant allergen immunotherapy with mass units-standardized extracts. Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166 [TBL] [Abstract][Full Text] [Related]
7. Clinical effects of hyposensitization using a purified allergen preparation from Timothy pollen as compared to crude aqueous extracts from Timothy pollen and a four-grass pollen mixture respectively. Frostad AB; Grimmer O; Sandvik L; Moxnes A; Aas K Clin Allergy; 1983 Jul; 13(4):337-57. PubMed ID: 6136346 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide. Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
10. An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever. Kay AB Drugs Today (Barc); 2007 Dec; 43(12):841-8. PubMed ID: 18174969 [TBL] [Abstract][Full Text] [Related]
11. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis. Rossi RE; Monasterolo G; Coco G; Operti D Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Varney VA; Gaga M; Frew AJ; Aber VR; Kay AB; Durham SR BMJ; 1991 Feb; 302(6771):265-9. PubMed ID: 1998791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]